Skip to main content

Duvyzat News

Monthly News Roundup - March 2024

Rezdiffra Approved as First Drug for Nonalcoholic Fatty Liver Disease (NASH)  In March, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Rezdiffra (resmetirom) for adults ...

FDA Approves Oral Duvyzat for Duchenne Muscular Dystrophy

MONDAY, March 25, 2024 – The U.S. Food and Drug Administration has approved Duvyzat (givinostat) as an oral medication for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of...

FDA Approves Duvyzat (givinostat) for Duchenne Muscular Dystrophy

MILAN--(BUSINESS WIRE)-- Mar 22, 2024 – Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has approved Duvyzat™ (givinostat), a novel histone deacetylase (HDAC) i...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Duchenne Muscular Dystrophy

Duvyzat patient information at Drugs.com